Rachel Therrien
Overview
Explore the profile of Rachel Therrien including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
45
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Laymouna M, Ma Y, Lessard D, Engler K, Therrien R, Schuster T, et al.
Healthcare (Basel)
. 2024 Aug;
12(16).
PMID: 39201222
Background: Pharmacists need up-to-date knowledge and decision-making support in HIV care. We aim to develop MARVIN-Pharma, an adapted artificial intelligence-based chatbot initially for people with HIV, to assist pharmacists in...
2.
Deschenes P, Luu Hoai M, Rinfret J, Pelletier S, Stortini A, Therrien R, et al.
Can J Hosp Pharm
. 2024 Jul;
77(3):e3552.
PMID: 38988872
Background: Simulations are used to improve professional practice across multiple health professions; however, the application of simulations in pharmacy curricula has been limited by a lack of evidence. Objectives: To...
3.
Ma Y, Achiche S, Pomey M, Paquette J, Adjtoutah N, Vicente S, et al.
JMIR Res Protoc
. 2024 Feb;
13:e54668.
PMID: 38349734
Background: Artificial intelligence (AI)-based chatbots could help address some of the challenges patients face in acquiring information essential to their self-health management, including unreliable sources and overburdened health care professionals....
4.
Bouchard A, Bourdeau F, Roger J, Taillefer V, Sheehan N, Schnitzer M, et al.
AIDS Res Hum Retroviruses
. 2021 Sep;
38(7):552-560.
PMID: 34538065
Despite availability of effective antiretroviral therapy (ART), many HIV patients still have a detectable viral load (VL). Predictive factors of detectable VL are not well documented. This study was done...
5.
Klein M, Baril J, Charron M, Fortin C, Lalonde R, Matte M, et al.
Can J Infect Dis Med Microbiol
. 2012 Sep;
22(3):88-96.
PMID: 22942885
The management and treatment of HIV and hepatitis B virus (HBV)-coinfected patients present specific challenges for clinicians. The morbidity and mortality related to these concomitant infections are growing concerns, while...
6.
Rachlis A, Angel J, Harris M, Shafran S, Therrien R, Tremblay C, et al.
Can J Infect Dis Med Microbiol
. 2010 Sep;
20(3):e67-80.
PMID: 20808458
Background And Objectives: A meeting of a Canadian group with significant experience and knowledge in HIV management, consisting of five physicians, a pharmacist and an AIDS researcher, was convened. Their...
7.
Talbot A, Machouf N, Thomas R, Marcotte S, Therrien R, Lessard B, et al.
J Acquir Immune Defic Syndr
. 2009 Jun;
51(3):362-4.
PMID: 19553775
No abstract available.
8.
Cote P, Baril J, Hebert M, Klein M, Lalonde R, Poliquin M, et al.
Can J Infect Dis Med Microbiol
. 2008 Oct;
18(5):293-303.
PMID: 18923731
Concomitant HIV and hepatitis C virus (HCV) is a common yet complex coinfection. The present document is a practical guide for treating HCV infection in people coinfected with HIV. Effective...
9.
Baril J, Junod P, Leblanc R, Dion H, Therrien R, Laplante F, et al.
Can J Infect Dis Med Microbiol
. 2007 Dec;
16(4):233-43.
PMID: 18159551
Approximately two years after the introduction of highly active antiretroviral therapy for the treatment of HIV infection, body shape changes and metabolic abnormalities were increasingly observed. Initially, these were ascribed...